GROGAN DONNA ROY - Insider Non-Derivative Transactions at C4 Therapeutics, Inc. (CCCC) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Oct 1, 2025, GROGAN DONNA ROY's relationship to C4 Therapeutics, Inc. (CCCC) is Director, and currently has 58,629 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other CCCC insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

GROGAN DONNA ROY - Insider Non-Derivative Transactions of CCCC Common Stock

GROGAN DONNA ROY - Insider Non-Derivative Transactions at CCCC

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Oct 2, 2025	Acquisition -- (Common Stock)	6740	2.15	58629
Jul 2, 2025	Acquisition -- (Common Stock)	9609	1.51	51889
Apr 2, 2025	Acquisition -- (Common Stock)	9581	1.44	42280
Jan 3, 2025	Acquisition -- (Common Stock)	3757	3.66	32699
Oct 2, 2024	Acquisition -- (Common Stock)	2474	5.56	28942
Jul 2, 2024	Acquisition -- (Common Stock)	2836	4.85	26468
Apr 2, 2024	Acquisition -- (Common Stock)	1697	8.1	23632
Jan 3, 2024	Acquisition -- (Common Stock)	2108	6.52	21935
Oct 3, 2023	Acquisition -- (Common Stock)	8089	1.7	19827
Jul 4, 2023	Acquisition -- (Common Stock)	4858	2.83	11738
Apr 4, 2023	Acquisition -- (Common Stock)	4298	3.2	6880
Jan 4, 2023	Acquisition -- (Common Stock)	1763	6.38	2582